|
|
Effect of folic acid on ischemic stroke complicated with H-type hypertension |
ZHAO Wenjun1 HAO Weihua1 LIN Wenjing1 SHI Yinhua2 LI Qing1 ZHAO Huiying1 ZHANG Jianping1 |
1.Department of Geriatrics, Shijiazhuang People’s Hospital, Hebei Province, Shijiazhuang 050000, China;
2.Department of Cardiac Surgery, Shijiazhuang People’s Hospital, Hebei Province, Shijiazhuang 050000, China |
|
|
Abstract Objective To investigate the effect of folic acid on ischemic stroke patients with H-type hypertension. Methods A total of 200 patients with ischemic stroke complicated with H-type hypertension admitted to Shijiazhuang People’s Hospital from December 2018 to December 2019 were selected, and they were divided into treatment group and routine group according to random number method, with 100 cases in each group. The routine group was given anti-platelet drugs, statins, anti-hypertensive drugs, improving cerebral circulation, and other basic treatments, and the treatment group was given folic acid orally on the basis of the routine group. The course of treatment in both groups was six months. The levels of homocysteine (Hcy), matrix metalloproteinase-9 (MMP-9), and Montreal cognitive assessment (MoCA) scale score were compared between the two groups before and after treatment. The correlation between MoCA score and Hcy, MMP-9 level was analyzed. Results After treatment, the levels of Hcy and MMP-9 in the treatment group were lower than those before treatment, and those in the treatment group were lower than those in the routine group, the differences were statistically significant (P < 0.05). After treatment, the MoCA scores of both groups were higher than those of before treatment, and the MoCA score of the treatment group was higher than that of the routine group, the differences were statistically significant (P < 0.05). Correlation analysis showed that Hcy and MMP-9 levels were negatively correlated with MoCA score (r < 0, P < 0.05). Conclusion Folic acid treatment can reduce Hcy and MMP-9 levels and improve MoCA score in patients with ischemic stroke complicated with H-type hypertension, which is worthy of further clinical promotion.
|
|
|
|
|
[1] Kong Y,Li X,Chang L,et al. Hypertension With High Homocysteine Is Associated With Default Network Gray Matter Loss [J]. Front Neurol,2021,12:740-819.
[2] Nyberg CK,Nordvik JE,Becker F,et al. A longitudinal study of computerized cognitive training in stroke patients-effects on cognitive function and white matter [J]. Top Stroke Rehabil,2018,25(4):241-247.
[3] 成战强.H型高血压与脑梗死后认知功能障碍的关系[J].国际精神病学杂志,2020,47(5):976-978.
[4] Ford AH,Almeida OP. Effect of Vitamin B Supplementation on Cognitive Function in the Elderly:A Systematic Review and Meta-Analysis [J]. Drugs Aging,2019,36(5):419-434.
[5] An Y,Feng L,Zhang X,et al. Dietary intakes and biomarker patterns of folate,vitamin B6,and vitamin B12 can be associated with cognitive impairment by hypermethylation of redox-related genes NUDT15 and TXNRD1 [J]. Clin Epigenetics,2019,11(1):139.
[6] Iadecola C,Gottesman RF. Neurovascular and Cognitive Dysfunction in Hypertension [J]. Circ Res,2019,124(7):1025-1044.
[7] Liu Y,Dong YH,Lyu PY,et al. Hypertension-Induced Cerebral Small Vessel Disease Leading to Cognitive Impairment [J]. Chin Med J(Engl),2018,131(5):615-619.
[8] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-682.
[9] Nasreddine ZS,Phillips NA,Bédirian V,et al. The Montreal Cognitive Assessment,MoCA:a brief screening tool for mild cognitive impairment [J]. J Am Geriatr Soc,2005,53(4):695-699.
[10] Cao Y,Su N,Zhang D,et al. Correlation between total homocysteine and cerebral small vessel disease:A Men-delian randomization study [J]. Eur J Neurol,2021,28(6):1931-1938.
[11] 赵晓玲,孙瑞红.脑小血管病与血清同型半胱氨酸相关性的研究进展[J].神经疾病与精神卫生,2021,21(6):452-456.
[12] ?譒kovierová H,Vidomanová E,Mahmood S,et al. The Molecular and Cellular Effect of Homocysteine Metabolism Imbalance on Human Health [J]. Int J Mol Sci,2016,17(10):1733.
[13] 贾晓云.马来酸依那普利叶酸片治疗H型高血压患者的效果及其与MTHFR基因多态性的相关性[J].广西医学,2021,43(5):545-548.
[14] Kaye AD,Jeha GM,Pham AD,et al. Folic Acid Supplementation in Patients with Elevated Homocysteine Levels [J]. Adv Ther,2020,37(10):4149-4164.
[15] 洪训宇.马来酸依那普利叶酸片对H型高血压患者同型半胱氨酸和血栓前状态的影响[J].中国临床药理学杂志,2020,311(9):8-11.
[16] 刘玉梅,张静.三阴乳腺癌患者乳腺不同组织RECK,HIF-1α,MMP-9蛋白表达水平变化及临床意义分析[J].中国医刊,2020,55(10):1104-1107.
[17] Zhong C,Bu X,Xu T,et al. Serum Matrix Metalloproteinase-9 and Cognitive Impairment After Acute Ischemic Stroke [J]. J Am Heart Assoc,2018,7(1):1-10.
[18] 徐吉光,李宇宁.叶酸联合维生素B12对高同型半胱氨酸血症引起大鼠动脉粥样硬化的治疗作用[J].吉林大学学报(医学版),2017,43(5):943-947.
[19] 韩晶,徐海,陶静.MMSE评分,MoCA评分和事件相关电位P300对不同部位脑卒中患者认知功能的评价研究[J].脑与神经疾病杂志,2018,26(8):481-485.
[20] Riega-Torres JCL,Trevi?觡o-Castro MA,Hernandez-Galarza IJ,et al. Cognitive dysfunction in Sj?觟gren’s syndrome using the Montreal Cognitive Assessment Questionnaire and the Automated Neuropsychological Assessment Metrics:A cross-sectional study [J]. Int J Rheum Dis,2020,23(8):1019-1023.
[21] 朱淼,徐树军,罗璇,等.急性脑卒中发病后认知功能改变的患者MRS与MoCA得分相关性分析[J].医学综述,2020,26(1):164-168.
[22] Alonso A,Szabo K,Wolf ME,et al. Acute Stroke Syndromes with Isolated Hypoperfusion on MRI-A Clinical and MRI Study [J]. Eur Neurol,2016,75(1/2):27-32.
[23] 刘丽君,韩智群,邓馨.同型半胱氨酸对血管性认知障碍患者的影响[J].武警医学,2020,31(6):29-31.
[24] 张丽,张学艳,马艳,等.缺血性脑卒中合并脑微出血患者认知功能及血清超敏C反应蛋白、神经元特异性烯醇化酶、同型半胱氨酸变化分析[J].临床军医杂志,2018, 46(1):84-85,87.
[25] Hassan A,Hunt BJ,O’Sullivan M,et al. Homocysteine is a risk factor for cerebral small vessel disease,acting via endothelial dysfunction [J]. Brain,2004,127(1):212-219.
[26] 庄俊鸿,云天,王年臻.脑梗死患者血清NO含量及MMP-9水平与认知障碍的关系[J].中华保健医学杂志,2018,20(4):340-341. |
|
|
|